U.S. Markets

US President Trump plans executive order splitting measles, mumps and rubella shots

StockNow breaking-news AI analysis

President Trump's plan to split the MMR vaccine increases regulatory risks for Merck (MRK), aligning with broader administration efforts led by RFK Jr. to scale back federal vaccination mandates.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more